The Brazil cardiac pacemakers market is estimated to be valued at US$ 319.82 Mn in 2023 and is expected to exhibit a CAGR of 2.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cardiac pacemakers are implantable medical devices that help correct irregular heartbeats by sending electrical impulses to the heart to help it maintain a regular rhythm. They are used to treat arrhythmias such as atrioventricular block, sick sinus syndrome, and bradycardia. The rising prevalence of cardiovascular diseases and increasing burden of heart conditions in Brazil are major factors augmenting the demand for cardiac pacemakers in the country.
Market Dynamics:
The Brazil cardiac pacemakers market is primarily driven by growing geriatric population, which is more prone to heart conditions, and increasing healthcare expenditure. According to WHO, Brazil's population aged 60 years and older is expected to surpass 30 million by 2025. Moreover, the government is focusing on expanding healthcare coverage and improving access to modern medical technologies like pacemakers. However, high cost of implanting pacemakers and presence of alternative treatment options are some challenges restraining the market growth.
SWOT Analysis
Strength: The Brazil cardiac pacemakers market is growing steadily due to increasing geriatric population and rising prevalence of cardiovascular diseases in the country. The Government support for healthcare sector development and favorable reimbursement policies are positively influencing the market growth. Product innovations with miniaturized devices and additional features are further strengthening the market.
Weakness: High cost of pacemaker devices and procedures limits their adoption in Brazil. Lack of awareness about newer technologies also restrain the market growth. Absence of skilled professionals poses challenge for effective operations.
Opportunity: Untapped rural areas represent major opportunity as cardiovascular issues are rising fast even in interior regions. Expanding distribution channels and strategic collaborations can aid in tapping rural healthcare needs. Development of affordable devices customized for Brazilian patients offer new opportunities.
Threats: Stringent regulatory approvals and reimbursement policies delay market access of new devices. Economic slowdowns impact the healthcare spending affecting the demand. Intense competition threatens the pricing and market shares of existing players.
Key Takeaways
The Brazil Cardiac Pacemakers Market Size is expected to witness high growth, exhibiting CAGR of 2.4% over the forecast period, due to increasing prevalence of cardiovascular diseases and aging population in Brazil.
Regional analysis:
The South East region dominated Brazil cardiac pacemakers market in 2021, accounting for over 35% share. This is owing to presence of large patient pool and developing healthcare infrastructure in states like Sao Paulo and Rio De Janeiro. North East region is expected to witness highest CAGR owing to government initiatives to strengthen healthcare sector in the region.
Key players:
Key players operating in the Brazil cardiac pacemakers market are BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, and MEDICO S.p.A. Major players are focused on developing advanced devices and establishing partnerships with local distributors to enhance market presence in Brazil.
Read more
https://www.rapidwebwire.com/brazil-cardiac-pacemakers-market-size-share-growth-outlook-2023/
